How can you effectively measure ROI on each of your individual marketing programs?

•Do you know which parts of your current pharmaceutical marketing programs are working and which are not?
•How do you measure ROI from your advertising, PR, symposia programs, or eDetailing spending?
•How can you improve your current pharmaceutical marketing mix?

Identify Their Impact

Knowing the impact of your different marketing programs, and how they compare against each other in terms of market share is essential to your pharmaceutical marketing.

First, you need to know what is working, and what is not. Then you need to know how to distribute spending across your pharmaceutical marketing program mix to optimize your returns.

But most of the tools that companies use to measure this impact do not effectively answer these 3 key questions.

Start with 98.4 Individual Program Analytics

Only Eularis 94.8 Individual Program Analytics shows you:
•Which of your current individual marketing activities have the most impact on actual prescribing
•How to rearrange your marketing mix and budget to optimise returns on your advertising, PR, medical education etc.
We improve your accuracy because we analyse current data, not historical. So Eularis 94.8 Individual Program Analytics delivers the highest degree of accuracy in measuring returns on each of your separate marketing programs.

Advertising: Get the Bottom Line

Take a second look at how you rate your advertising. Pharmaceutical companies use a range of metrics tools for measuring advertising effectiveness, including:

Advertising Measuring Tools

•Brand awareness
•Ad awareness
•Consumer purchases
•Brand images and attributes
•Recall of advertising content
•Brand preference/ranking
•Advertising vividness measures
•Purchase-related promotions
•Prices
•Sizes/varieties
•Distribution

However, all of these methods only track activity. They do not tell you whether the advertising is influencing your brand prescribing or not. And if it is, they do not say by how much.
Now Eularis 94.8 Individual Program Analytics can provide you with the bottom line on how your advertising affects your brand prescribing, and to what extent it does this. This unique 94.8 Analytics system gives you these answers in addition to the data you will get from the other advertising measuring tools, shown above.

PR: Take the Next Step

•Public relations has a major impact on pharmaceutical brand and corporate marketing
•But how do you separate and measure the ROI you get from your PR?
•How could you improve your PR activities to optimize your return?

You will not find all the answers you need from traditional PR measures such as number of placements, attendance at events, press clippings, column inches etc. But modern PR measurement has advanced significantly. Take the next step in measuring your PR with Eularis 94.8 Individual Program Analytics,

Measure PR with Individual Program Analytics, and find out:

•How much of your market share is being providing from specific PR target audiences
•How much return is provided by the different PR activities (e.g. journal write-ups versus events, versus social investments versus press releases etc)
•How your PR marketing mix could be tweaked to gain an even greater return
•The likely return if you invest specific amounts in certain PR programs
•The relationship between product branding and corporate branding
•Which PR firms are at the top of the league table in terms of providing maximum market share impact for their client brands

Using Eularis 94.8 Individual Program Analytics, any brand marketer can know the market share impact from the individual marketing programs and how they compare against each other.

Receive Case Studies

CONTACT US TODAY FOR YOUR FREE CASE STUDIES AND DEMONSTRATION OF 94.8 ANALYTICS IN ACTION WITH REAL PHARMACEUTICAL BRANDS.

Client Quotes

Powerful stuff. In my 20 years of marketing I have never seen such valuable data on my drug brands.' Specialist Team Leader, Pfizer

'It provides a level of insight which has been difficult to obtain using existing tools. The team were impressed by its ability to predict market share movements based on mix investment decisions.' Brand Manager, GlaxoSmithKline

'It actually does what it says on the tin.' Business Intelligence Manager, Boehringer Ingelheim.

'Your system allowed us all to fully understand just how our overall company and its brands were perceived versus our competitors and what we were required to do in order to grow. Importantly, having a tool available that allowed us to predict whether or not our market share would grow or decline was invaluable as it allowed us for the first time to realistically evaluate our efforts and investments.' CEO, AstraZeneca

'We always had the problem that we had a lot of data but it still required guesswork and gut feeling to get us to our strategic marketing decisions. I wasn't sure you would be able to show me more than I already knew. However, this workshop really showed me how to connect the data and the decisions and we have now got repeatable improving sales results from implementing this!' Attendee from Eularis Workshop on ROI

Why Invest In These Analytics

Independent research on our system showed an accuracy of 94.8% over several years.

Even if not budgeted for, the system pays for itself with the ongoing rise in market share from accurate message focus and marketing mix allocation

You get a few key specific actionable recommendations that will have maximum impact on your brand sales/market share over next 6 months

Eularis analytics offer brands the bottom line facts: which messages, which specific sales and marketing activities (e.g. sales, advertising, journal write-ups, CME, patient programmes etc) are truly impacting a brands prescription sales - how much - and how should the marketing mix budget be allocated for maximum $ results moving forward.

CONTACT US TODAY FOR ANY FURTHER INFORMATION ON ANY ASPECT OR TO SCHEDULE A MEETING FOR A DEMONSTRATION.